Beginning next week, the U.K is now set to get its rollout of Pfizer ‘s controversial COVID-19 vaccine. Last night, regulators and officials met at breakneck speeds for several hours determining how it will be distributed; to whom, and to what groups first.
“The government has today accepted the recommendation from the independent Medicines and Healthcare products Regulatory Agency (MHRA) to approve Pfizer-BioNTech’s Covid-19 vaccine for use,” the government said Wednesday. “The vaccine will be made available across the U.K. from next week.”
Pfizer’s Chairman and CEO, Albert Bourla, said the authorization was a “historic moment.” It is unknown at this time who will get the two-dose vaccine first. The U.K will have enough vaccinations to vaccinate about a third of its 66m population.
“This authorization is a goal we have been working toward since we first declared that science will win, and we applaud the MHRA for their ability to conduct a careful assessment and take timely action to help protect the people of the U.K.,” he said.
“With thousands of people becoming infected, every day matters in the collective race to end this devastating pandemic.”